Page last updated: 2024-09-05

sb 203580 and beta-elemene

sb 203580 has been researched along with beta-elemene in 1 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (beta-elemene)	Trials (beta-elemene)	Recent Studies (post-2010) (beta-elemene)
3,489	4	1,137	258	1	211

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ding, X; Huang, CX; Jia, YC; Wang, YZ; Xu, YH; Yao, YQ	1

Other Studies

1 other study(ies) available for sb 203580 and beta-elemene

Article	Year
Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer letters, 2008, Jun-08, Volume: 264, Issue:1 Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Enzyme Inhibitors; Glioblastoma; Humans; Imidazoles; Mice; Mice, Nude; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Sesquiterpenes; Signal Transduction; Xenograft Model Antitumor Assays	2008

Article

Year

Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation.

Cancer letters, 2008, Jun-08, Volume: 264, Issue:1

Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Enzyme Inhibitors; Glioblastoma; Humans; Imidazoles; Mice; Mice, Nude; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Sesquiterpenes; Signal Transduction; Xenograft Model Antitumor Assays

2008